Showing results (461-470 of 2,509) with videos related to
Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|April 16, 2015
Prognostic effect of comorbidity indices in elderly patients with multiple myelomaJelena Bila, Jelena Jelicic, Vladislava Djurasinovic, et al.Clinical Lymphoma, Myeloma & Leukemia|July 9, 2020
Role of Allogeneic HCT as Postremission Therapy for Transplant-Eligible Adult Lymphoblastic Leukemia/Lymphoma After Frontline Hyper-CVADMoussab Damlaj, Mohammad Snnallah, Razan Bashir, et al.Clinical Lymphoma, Myeloma & Leukemia|July 15, 2020
Evaluation of Montelukast for the Prevention of Infusion-related Reactions With DaratumumabDonald C Moore, Justin R Arnall, Daniel L Thompson, et al.Clinical Lymphoma, Myeloma & Leukemia|July 16, 2020
Outcomes of Treatment for HIV-Infected Lymphoma Patients: A National Cancer Database (NCDB) AnalysisThejus T Jayakrishnan, Veli Bakalov, Yazan Samhouri, et al.Clinical Lymphoma, Myeloma & Leukemia|January 21, 2014
Phase I and extension study of clofarabine plus cyclophosphamide in patients with relapsed/refractory acute lymphoblastic leukemiaStefan Faderl, Kumudha Balakrishnan, Deborah A Thomas, et al.Clinical Lymphoma, Myeloma & Leukemia|November 10, 2012
Clinical prognostic factors for survival and risk of progression to acute myeloid leukemia in patients with myelodysplastic syndromes with < 10% marrow blasts and non-unfavorable cytogenetic categoriesJose F Falantes, Cristina Calderón, Francisco J Márquez Malaver, et al.Clinical Lymphoma, Myeloma & Leukemia|January 15, 2014
Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugsMassimo Martino, Maurizio Postorino, Giuseppe Alberto Gallo, et al.Clinical Lymphoma, Myeloma & Leukemia|January 15, 2014
High-dose vincristine sulfate liposome injection (Marqibo) Is not associated with clinically meaningful hematologic toxicityOlivia R Deitcher, John Glaspy, Rene Gonzalez, et al.Clinical Lymphoma, Myeloma & Leukemia|November 14, 2012
A risk-adapted protocol for delayed administration of filgrastim after high-dose chemotherapy and autologous stem cell transplantationAmit Khot, Michael Dickinson, Kerrie Stokes, et al.Clinical Lymphoma, Myeloma & Leukemia|October 9, 2012
Age, race, sex, stage, and incidence of cutaneous lymphomaLynn D Wilson, Ginette A Hinds, James B YuPageof 251